Juno Therapeutics, INC.
0 sources
Juno Therapeutics, INC.
Summary
Juno Therapeutics, INC. is a business[1].
Key Facts
- Juno Therapeutics, INC. is in the country of US[2].
- Juno Therapeutics, INC.'s instance of is recorded as business[3].
- 2013-08-05 marks the founding of Juno Therapeutics, INC.[4].
- Juno Therapeutics, INC.'s parent organization or unit is recorded as Celgene[5].
- Juno Therapeutics, INC.'s parent organization or unit is recorded as Bristol-Myers Squibb[6].
- Juno Therapeutics, INC.'s legal form is recorded as XTIQ[7].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 5493004CAOW3ZGG2CV25[8]
-
Registered legal name: Juno Therapeutics, INC.[9]
-
Legal jurisdiction: US-DE[10]
-
GLEIF entity category: GENERAL[11]
-
Legal form (ISO 20275 ELF): XTIQ[12]
-
Entity status: ACTIVE[13]
-
LEI registration status: ISSUED[14]
-
Entity created: 2013-08-05[15]
-
LEI first registered: 2014-11-04[16]
-
LEI last updated: 2026-02-10[17]
-
LEI next renewal: 2027-02-11[18]
-
Managing LOU: 5493001KJTIIGC8Y1R12[19]
-
Registration authority: RA000602[20]
-
Authority entity ID: 5378373[21]
-
Conformity flag: CONFORMING[22]
Body
Founding
2013-08-05 marks the founding of Juno Therapeutics, INC.[4].
Operations
Parent organizations include Celgene[5], a business[23], in United States[24], founded in 1986[25], headquartered in Summit[26] and Bristol-Myers Squibb[6], an enterprise[27], in United States[28], founded in 1989[29], headquartered in New York City[30].